股本和储备 更改
Abbott USD 52.06B 69M 2026-03
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Agios Pharmaceuticals USD 1.03B 83.09M 2026-06
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alnylam Pharmaceuticals USD 1.35B 278.74M 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Coherus Biosciences USD 61.01M 26.76M 2025-12
Eli Lilly USD 31.2B 4.66B 2026-03
Halozyme Therapeutics USD 219.64M 170.82M 2026-03
Illumina USD 2.68B 47M 2026-03
Insmed USD 704.85M 34.12M 2026-03
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
J&J USD 84.97B 3.78B 2026-06
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
MacroGenics USD 21.2M 34.39M 2026-03
MannKind USD -59.2M 8.17M 2026-03
Merck USD 45.88B 6.73B 2026-03
Moderna USD 7.41B 1.24B 2026-03
Novartis USD 41.95B 3.02B 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Puma Biotechnology USD 115.27M 10.55M 2025-09
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Ultragenyx Pharmaceutical USD -236M 156M 2026-03
United Therapeutics USD 5.9B 1.2B 2026-03
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12